Yubo International Biotech Ltd (YBGJ)
0.77
-0.03
(-3.75%)
USD |
OTCM |
May 20, 16:00
Yubo International Biotech Cash from Operations (TTM): -0.739M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.739M |
| September 30, 2023 | -0.8701M |
| June 30, 2023 | -0.8199M |
| March 31, 2023 | -0.6846M |
| December 31, 2022 | -0.601M |
| September 30, 2022 | 0.0249M |
| June 30, 2022 | -0.0612M |
| Date | Value |
|---|---|
| March 31, 2022 | 0.0327M |
| December 31, 2021 | -1.021M |
| September 30, 2021 | -0.4442M |
| June 30, 2021 | -0.5395M |
| March 31, 2021 | -0.4099M |
| December 31, 2020 | 0.1011M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-1.021M
Minimum
Dec 2021
0.1011M
Maximum
Dec 2020
-0.464M
Average
-0.5395M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
| Meihua International Medical Technologies Co Ltd | 2.276M |
| Hologic Inc | 1.104B |
| Nuwellis Inc | -14.69M |
| Varex Imaging Corp | 98.20M |
| Quanterix Corp | -29.56M |